MRK
Merck & Co., Inc. · Healthcare
EVP and CHRO Steven Mizell sold $2.5M of Merck & Co., Inc.
Sold$2,490,720
$99.63Price
25,000Shares
−44%Stake
What MRK did after the filing
- The stock from Wed, Nov 2 open, $99.65
- +10.0%
- S&P 500, same days
- +1.5%
Measured over 30 trading days, to the Dec 15 close.
Traded Fri, Oct 28. Filed Tue, Nov 1, 4:33 PM ET, after the close. Returns use the Nov 2 open and the Dec 15 close. Not investment advice.